Dark Forest Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Dark Forest Capital Management’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5,128	Closed	-$191K	–	1515
2023 Q1	$191K	Buy	+5,128	New	+$231K	0.05%	407
2022 Q4	–	Sell	-52	Closed	-$4K	–	1576
2022 Q3	$4K	Buy	+52	New	+$3.85K	﹤0.01%	953
2022 Q1	–	Sell	-2	Closed	–	–	1890
2021 Q4	$0	Sell	2 -48	-96%	-$7.45K	﹤0.01%	1862
2021 Q3	$9K	Buy	+50	New	+$8.04K	﹤0.01%	1015

Other funds holding MRTX

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Dark Forest Capital Management's MRTX Position: Q2 2023 in Review

Dark Forest Capital Management sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q2 2023, closing a stake of 5,128 shares — an estimated $191K sold.

Dark Forest Capital Management first reported a position in MRTX in Q3 2021 and held it in 4 quarters. The position peaked at $191K in Q1 2023. 207 funds tracked by Wall St. Rank hold MRTX as of Q2 2023.

Dark Forest Capital Management reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Dark Forest Capital Management sold 5,128 Mirati Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $191K.
Dark Forest Capital Management first reported a position in Mirati Therapeutics, Inc. Common Stock in Q3 2021 and held it in 4 quarters.
Dark Forest Capital Management's Mirati Therapeutics, Inc. Common Stock position peaked at $191K in Q1 2023.
207 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Dark Forest Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.